+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Forecast 2024-2030- Product Image
Global Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887534
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Generic Injectables Market size was estimated at USD 33.12 billion in 2023, USD 36.58 billion in 2024, and is expected to grow at a CAGR of 10.64% to reach USD 67.22 billion by 2030.

Generic injectables are non-branded pharmaceuticals that are administered by injection and have the same active ingredients, strength, dosage form, route of administration, quality, performance characteristics, and intended use as their branded counterparts. They are typically marketed after the original branded product's patent protection has expired.

Generic injectables offer a cost-effective alternative to brand-name drugs, thereby contributing to healthcare savings and increased accessibility for patients. The generic injectables market is fueled by the increasing demand for more affordable pharmaceuticals and the expiration of patents for multiple branded injectables, which allows generic versions to enter the market.

Cost-containment policies by governments worldwide also drive the uptake of cost-effective generic injectables. In addition, the rise in the prevalence of chronic diseases that require injectable drugs for treatment supports the market growth. Despite the promising growth, the market faces challenges due to maintaining high-quality standards, which, if not adequately managed, can lead to recalls and reputational damage. Furthermore, the market is subject to intense competition and price erosion, which can hinder the adoption of generic injectables. However, research focusing on advanced drug delivery systems, biosimilar development, sustainable production, and formulation advancements to improve product stability and storage presents lucrative opportunities for market expansion.

Regional Insights

The market for generic injectables in the Americas, and particularly in the United States, has seen significant growth. The expiration of patents for branded drugs, government initiatives to minimize healthcare costs, and the rising prevalence of chronic diseases have resulted in a surging need for affordable generic alternatives in this region. The Americas region benefits from a well-developed healthcare sector and a competitive market landscape where numerous players are constantly engaged in the introduction of new products and cost-effective manufacturing processes. The Europe, Middle East, and Africa (EMEA) region has experienced steady growth in the generic injectables market.

This performance is facilitated by supportive governmental health policies aimed at promoting the use of generics, as well as an emphasis on biosimilars. The European market, in particular, benefits from stringent regulatory standards that ensure high-quality products, while cost-effectiveness remains a driving factor behind the widespread adoption of generic injectables. In the Middle East and Africa, the market is steadily evolving with the improving healthcare infrastructure and increased accessibility to medication. The Asia-Pacific (APAC) region is currently witnessing rapid expansion in the generic injectables sector. India and China, with their vast population base, increasing healthcare expenditure, and supportive government policies for generic medicine production, are contributing significantly to this growth. The region also hosts a significant number of generic drug manufacturers, which bolster the local market growth. Additionally, the growing incidence of chronic conditions, coupled with a concerted effort to enhance healthcare systems in emerging economies, provides a robust platform for the growth of the generic injectables market in APAC.

Market Trends by Segment

  • Product: Growing consumption of small molecule injectables in various therapeutic areas owing to their accessibility and familiarity
  • Type: Demand for generic cytokines and monoclonal antibodies in ongoing R&D for cost-effective novel therapies
  • Application: Significant benefits of generic injectables in cardiology and oncology, requiring long-term and sustainable medication costs
  • Distribution Channel: Inclining preferences for online stores offering convenience and competitive pricing

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Gland Pharma gets USFDA nod for generic injectable

Gland Pharma announced its approval from the US FDA to market its generic version of Angiotensin II Injection, presented in a 2.5 mg/mL single-dose vial. The company's advancements underscore its commitment to enhancing its portfolio in the generic injectables market, ensuring the availability of essential medications within the healthcare system.

Meitheal Pharmaceuticals Announces Expansion of Portfolio of Generic Injectable Products

Meitheal Pharmaceuticals, Inc., part of the fully integrated generic injectables field, has significantly broadened its market offerings through a recent deal orchestrated by Hong Kong King-Friend Industry Co., Ltd. (HKF), their parent entity. The asset purchase agreement detailed by the two organizations leads to an impressive uptick in Meitheal's generic injectable repertoire.

Endo Launches First Generic Version of Noxafil (posaconazole) Injection

Endo International plc's subsidiary Par Sterile Products has launched the U.S. market's inaugural generic form of Merck's Noxafil with its posaconazole injection (18 mg/mL), following the U.S. Food and Drug Administration's approval of their Abbreviated New Drug Application. This is a significant milestone for Endo, highlighting its commitment to expanding treatment options for healthcare professionals, enhancing its offerings, and affirming its status as a dependable provider of quality pharmaceuticals.

Key Company Profiles

The report delves into recent significant developments in the Generic Injectables Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Baxter International Inc., Biocon Limited, Biological E. Limited, Bristol-Myers Squibb Company, Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International PLC, Eugia US LLC, Fresenius Kabi AG, Gland Pharma Limited by Shanghai Fosun Pharmaceutical Co., Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lupin Limited, Meitheal Pharmaceuticals, Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Samsung Biologics Co., Ltd., Sanofi S.A., Somerset Pharma, LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Generic Injectables Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for cost-effective medications
5.1.1.2. Increasing patent expirations and emphasis on adopting generic drugs
5.1.1.3. Favorable government approvals for generic drugs & injectables
5.1.2. Restraints
5.1.2.1. Preference for branded drugs by patients and physicians
5.1.3. Opportunities
5.1.3.1. Ongoing R&D activities associated with generic injectable drugs
5.1.3.2. Strategic long-term partnerships to manufacture generic injectables
5.1.4. Challenges
5.1.4.1. Concerns associated with injectable quality and manufacturing variability
5.2. Market Segmentation Analysis
5.2.1. Product: Growing consumption of small molecule injectables in various therapeutic areas owing to their accessibility and familiarity
5.2.2. Type: Demand for generic cytokines and monoclonal antibodies in ongoing R&D for cost-effective novel therapies
5.2.3. Application: Significant benefits of generic injectables in cardiology and oncology, requiring long-term and sustainable medication costs
5.2.4. Distribution Channel: Inclining preferences for online stores offering convenience and competitive pricing
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Generic Injectables Market, by Product
6.1. Introduction
6.2. Large Molecule Injectables
6.3. Small Molecule Injectables
7. Generic Injectables Market, by Type
7.1. Introduction
7.2. Cytokines
7.3. Insulin
7.4. Monoclonal Antibodies
7.5. Vaccines
8. Generic Injectables Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Diabetes
8.4. Immunology
8.5. Oncology
9. Generic Injectables Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Prescription Stores
9.4. Retail Pharmacy
10. Americas Generic Injectables Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Generic Injectables Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Generic Injectables Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Gland Pharma gets USFDA nod for generic injectable
13.3.2. Meitheal Pharmaceuticals Announces Expansion of Portfolio of Generic Injectable Products
13.3.3. Endo Launches First Generic Version of Noxafil (posaconazole) Injection
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. GENERIC INJECTABLES MARKET RESEARCH PROCESS
FIGURE 2. GENERIC INJECTABLES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENERIC INJECTABLES MARKET DYNAMICS
FIGURE 7. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GENERIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GENERIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENERIC INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE MOLECULE INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE MOLECULE INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SMALL MOLECULE INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SMALL MOLECULE INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOKINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE PRESCRIPTION STORES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE PRESCRIPTION STORES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 67. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. CANADA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. CANADA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. CANADA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. CANADA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. CANADA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 74. CANADA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 75. MEXICO GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. MEXICO GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. MEXICO GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. MEXICO GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. MEXICO GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. MEXICO GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. CHINA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. CHINA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. CHINA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. CHINA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. CHINA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. CHINA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. CHINA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 118. CHINA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 119. INDIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. INDIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. INDIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. INDIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. INDIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. INDIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. INDIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. INDIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. JAPAN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. JAPAN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. JAPAN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. JAPAN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. JAPAN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. JAPAN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. JAPAN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 142. JAPAN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. THAILAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. THAILAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. THAILAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. THAILAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. THAILAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. THAILAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. THAILAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. THAILAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 209. DENMARK GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. DENMARK GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. DENMARK GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. DENMARK GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. DENMARK GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. DENMARK GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. DENMARK GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 216. DENMARK GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 217. EGYPT GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. EGYPT GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. EGYPT GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. EGYPT GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. EGYPT GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. EGYPT GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. EGYPT GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. EGYPT GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. FINLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. FINLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. FINLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. FINLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. FINLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. FINLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. FINLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 232. FINLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 233. FRANCE GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. FRANCE GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. FRANCE GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. FRANCE GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. FRANCE GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. FRANCE GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FRANCE GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 240. FRANCE GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 241. GERMANY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. GERMANY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. GERMANY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. GERMANY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. GERMANY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. GERMANY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. GERMANY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. GERMANY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. ITALY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. ITALY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. ITALY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. ITALY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. ITALY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. ITALY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ITALY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 264. ITALY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. NORWAY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. NORWAY GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. NORWAY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. NORWAY GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. NORWAY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NORWAY GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NORWAY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 288. NORWAY GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 289. POLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. POLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. POLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. POLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. POLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. POLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. POLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. POLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. QATAR GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. QATAR GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. QATAR GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 300. QATAR GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 301. QATAR GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. QATAR GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. QATAR GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 304. QATAR GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 329. SPAIN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. SPAIN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. SPAIN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 332. SPAIN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 333. SPAIN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SPAIN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SPAIN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. SPAIN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 353. TURKEY

Companies Mentioned

  • Amgen Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Baxter International Inc.
  • Biocon Limited
  • Biological E. Limited
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Endo International PLC
  • Eugia US LLC
  • Fresenius Kabi AG
  • Gland Pharma Limited by Shanghai Fosun Pharmaceutical Co., Ltd.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Meitheal Pharmaceuticals, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Samsung Biologics Co., Ltd.
  • Sanofi S.A.
  • Somerset Pharma, LLC
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 36.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.22 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Generic Injectables Global Market Report 2024 - Product Image

Generic Injectables Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Generic Oncology Sterile Injectable Global Market Report 2024 - Product Image

Generic Oncology Sterile Injectable Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032 - Product Image

Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Generic Injectables - Global Strategic Business Report - Product Image

Generic Injectables - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Specialty Injectable Generic Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Image

Specialty Injectable Generic Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • 110 Pages
  • Global
From

About the Generic Injectable Market

The Generic Injectable market is a segment of the drug delivery industry that focuses on the production and distribution of generic injectable drugs. These drugs are typically administered via injection and are used to treat a variety of medical conditions. Generic injectables are typically cheaper than their branded counterparts, making them a popular choice for patients and healthcare providers alike. Generic injectables are typically produced in bulk and then packaged and distributed to pharmacies and hospitals. The production process involves the use of sterile manufacturing techniques and quality control measures to ensure the safety and efficacy of the drugs. Generic injectables are an important part of the drug delivery industry, as they provide an affordable and effective way to treat a variety of medical conditions. Some companies in the Generic Injectable market include Hospira, Mylan, Teva Pharmaceuticals, Sandoz, and Fresenius Kabi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.